EdiShorts

For Antibiotics, the Right Dose Is Restraint — India's Antimicrobial Resistance Crisis

IssueJuly 2026
PaperGS Paper 3
SubjectScience & Technology
Read time3 min

Context: A Lancet Public Health study finds India's antibiotic consumption has crossed an “inflection point” — overusing the stronger “watch” category antibiotics meant for resistant infections while underusing safer first-line “access” drugs — a dangerous imbalance accelerating antimicrobial resistance (AMR) nationwide.

Key Facts

  • India's overall antibiotic use stands at 18.3 DDD (Defined Daily Dose) per 1,000 people/day, above the WHO-recommended optimal range of 9.9–14.7 DDD.
  • “Watch” category antibiotics (reserved for more resistant infections) are used at 9.3 DDD against a recommended 6 DDD — clear overuse.
  • “Access” category antibiotics (first-line, for common infections) are used at only 4.5 DDD against the level actually needed — clear underuse.
  • The National Action Plan on Antimicrobial Resistance 2.0 (2025–2029) is the government's current framework addressing the problem.

Why the Imbalance Exists

  • Patient demand for “quick cures,” doctors' convenience in overstretched clinical settings, and poor diagnostic access all push prescribing toward stronger drugs by default rather than by clinical necessity.
  • Liberal, often unregulated antibiotic use in livestock and agriculture compounds the human-health picture — resistance doesn't stay contained within one sector.
  • Weak retail-level enforcement enables over-the-counter antibiotic sales and irrational fixed-dose combinations that bypass proper prescribing altogether.

Significance

  • High AMR rates threaten to make common infections untreatable, raising morbidity, mortality and healthcare costs across the country.
  • Economic costs compound through lost productivity from prolonged illness and higher treatment expenses.
  • AMR is inherently a One Health problem — human, animal and agricultural antibiotic use are linked, so fixing only one domain won't solve it.

Way Forward

  • Build robust antimicrobial stewardship programmes in hospitals and clinics to guide evidence-based, not default, prescribing.
  • Expand access to affordable, rapid diagnostics so treatment can be targeted rather than empirical broad-spectrum by default.
  • Tighten enforcement against over-the-counter antibiotic sales and irrational fixed-dose combinations.
  • Regulate antibiotic use in animal husbandry and agriculture as part of an integrated One Health strategy, not a separate track.

Exam Angle — Prelims & Mains

  • UPSC PYQ Link (Mains 2023, GS Paper 3): "Antimicrobial resistance (AMR) poses a significant threat to global public health and food security. Discuss the challenges in combating AMR in India and suggest comprehensive strategies, including the 'One Health' approach, to mitigate this crisis." — Use the Lancet study's specific DDD data as your evidence base.
  • Practice Mains Question (GS Paper 2, 15 marks, 250 words): Critically analyze the current antibiotic usage patterns in India as highlighted by recent studies, and discuss the implications of this trend for public health and the economy.
  • Prelims Angle: Remember the WHO's three-tier antibiotic classification — Access, Watch, Reserve — and that DDD (Defined Daily Dose) is the standard unit for measuring drug consumption.
    • Practice Prelims MCQ: With reference to the WHO classification of antibiotics and their usage in India, consider the following statements:
      1. “Access” antibiotics are recommended as first-line treatments for common infections.
      2. India's current usage of “watch” antibiotics is below WHO-recommended levels.
      3. A recent study found India over-relies on stronger antibiotics even as safer first-line drugs remain underused.
      Options: (A) 1 and 2 only | (B) 2 and 3 only | (C) 1 and 3 only | (D) 1, 2 and 3
      Show answer
      Answer: (C) 1 and 3 only — Statement 1 is CORRECT — “Access” drugs are the WHO's designated first-line treatments for common infections.

Statement 2 is INCORRECT — India's “watch” antibiotic use (9.3 DDD) exceeds, not falls below, the recommended 6 DDD.

Statement 3 is CORRECT — the study explicitly documents over-reliance on stronger drugs alongside underuse of first-line “access” antibiotics.

More Science & Technology from July 2026

Written by the EdiShorts editorial team from official and public sources. Check the latest position before quoting figures in the exam.